LSIPR 50 2017: John Mendlein


John Mendlein was selected in the LSIPR 50 2017 publication for his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports.

Name: John Mendlein

Organisation: aTyr Pharma

Position: CEO

John Mendlein, aTyr Pharma, physiocrines, cellular activities, immune system, tissue damage, autoimmune, BIO